IMI markets a family of surgical probes including Gamma Probes for sentinel lymph node mapping and PET Probes for tumor detection.

Our technology is based on the injection of radio-pharmaceuticals that emit gamma or beta rays. Surgeons use our probes to locate the sentinel node and cancerous tissues that accumulate the radio-pharmaceuticals.